Literature DB >> 34293030

Abundant intratumoral fibrosis prevents lymphocyte infiltration into peritoneal metastases of colorectal cancer.

En Wang1, Masatsune Shibutani1, Hisashi Nagahara1, Tatsunari Fukuoka1, Yasuhito Iseki1, Yuki Okazaki1, Shinichiro Kashiwagi2, Hiroaki Tanaka1, Kiyoshi Maeda3, Kosei Hirakawa1, Masaichi Ohira1.   

Abstract

BACKGROUND: Tumor-infiltrating lymphocytes (TILs) have been reported to reflect the anti-tumor immune status. However, recent investigations have demonstrated that intratumoral fibrosis is important as a factor affecting the infiltration of TILs. This study investigated the organ specificities of TIL infiltration and intratumoral fibrosis in primary colorectal cancer and distant metastases, as well as the relationship between the distribution of TILs and intratumoral fibrosis.
METHODS: Patients who underwent resection of primary tumors or distant metastases for colorectal cancer with distant metastases were enrolled. We evaluated the TIL infiltration by immunohistochemical staining with CD3&CD8 and intratumoral fibrosis by immunohistochemical staining with α-SMA positive cancer-associated fibroblasts and Masson's trichrome staining against collagen fibers. The "ImageJ" was used to evaluate fibrosis, and the density of TILs in the dense and sparse areas of fibrosis was calculated. The Immunoscore (IS) was obtained based on the density of CD3+/CD8+TILs in the tumor center and invasive margin of the primary tumor.
RESULTS: The degree of CD3+/CD8+TIL infiltration in peritoneal metastases was significantly lower than that in liver and lung metastases. The area ratio of α-SMA positive cancer-associated fibroblasts and collagen fibers in peritoneal metastases was significantly higher than that of liver and lung metastases. Furthermore, the density of TILs in the high-fibrosis area was significantly lower than that in the low-fibrosis area. In the high-IS group of primary tumors, the degree of TIL infiltration in distant metastases was significantly higher than that in the low-IS group.
CONCLUSION: The infiltration of T lymphocytes into tumors is prevented in peritoneal metastases of colorectal cancer due to the high intratumoral fibrosis, which may lead to treatment resistance and a poor prognosis.

Entities:  

Year:  2021        PMID: 34293030     DOI: 10.1371/journal.pone.0255049

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  51 in total

Review 1.  The liver as a lymphoid organ.

Authors:  Ian Nicholas Crispe
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

2.  Low infiltration of peritumoral regulatory T cells predicts worse outcome following resection of colorectal liver metastases.

Authors:  Kazuya Nakagawa; Kuniya Tanaka; Yuki Homma; Kazunori Nojiri; Takafumi Kumamoto; Kazuhisa Takeda; Itaru Endo
Journal:  Ann Surg Oncol       Date:  2014-08-14       Impact factor: 5.344

3.  CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer.

Authors:  Elda Righi; Satoshi Kashiwagi; Jianping Yuan; Michael Santosuosso; Pierre Leblanc; Rachel Ingraham; Benjamin Forbes; Beth Edelblute; Brian Collette; Deyin Xing; Magdalena Kowalski; Maria Cristina Mingari; Fabrizio Vianello; Michael Birrer; Sandra Orsulic; Glenn Dranoff; Mark C Poznansky
Journal:  Cancer Res       Date:  2011-07-08       Impact factor: 12.701

Review 4.  Immunity, tolerance and autoimmunity in the liver: A comprehensive review.

Authors:  Derek G Doherty
Journal:  J Autoimmun       Date:  2015-09-07       Impact factor: 7.094

Review 5.  Immune surveillance by the liver.

Authors:  Craig N Jenne; Paul Kubes
Journal:  Nat Immunol       Date:  2013-09-18       Impact factor: 25.606

6.  Clinical impact of tumor-infiltrating lymphocytes for survival in curatively resected stage IV colon cancer with isolated liver or lung metastasis.

Authors:  Won-Suk Lee; Myunghee Kang; Jeong-Heum Baek; Jae-Ik Lee; Seung Yeon Ha
Journal:  Ann Surg Oncol       Date:  2012-12-06       Impact factor: 5.344

7.  The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer.

Authors:  K Canna; P A McArdle; D C McMillan; A-M McNicol; G W Smith; R F McKee; C S McArdle
Journal:  Br J Cancer       Date:  2005-02-28       Impact factor: 7.640

8.  Human subperitoneal fibroblast and cancer cell interaction creates microenvironment that enhances tumor progression and metastasis.

Authors:  Motohiro Kojima; Youichi Higuchi; Mitsuru Yokota; Genichiro Ishii; Norio Saito; Kazuhiko Aoyagi; Hiroki Sasaki; Atsushi Ochiai
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

9.  Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer.

Authors:  Shinji Matsutani; Masatsune Shibutani; Kiyoshi Maeda; Hisashi Nagahara; Tatsunari Fukuoka; Shigetomi Nakao; Kosei Hirakawa; Masaichi Ohira
Journal:  Cancer Sci       Date:  2018-03-25       Impact factor: 6.716

Review 10.  Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma: the 3d English Edition [Secondary Publication].

Authors: 
Journal:  J Anus Rectum Colon       Date:  2019-10-30
View more
  3 in total

Review 1.  Advances in the management of peritoneal malignancies.

Authors:  Vahan Kepenekian; Aditi Bhatt; Julien Péron; Mohammad Alyami; Nazim Benzerdjeb; Naoual Bakrin; Claire Falandry; Guillaume Passot; Pascal Rousset; Olivier Glehen
Journal:  Nat Rev Clin Oncol       Date:  2022-09-07       Impact factor: 65.011

2.  Senescent Tumor Cells in the Peritoneal Carcinomatosis Drive Immunosenescence in the Tumor Microenvironment.

Authors:  Heidi Braumüller; Bernhard Mauerer; Christopher Berlin; Dorothea Plundrich; Patrick Marbach; Pierre Cauchy; Claudia Laessle; Esther Biesel; Philipp Anton Holzner; Rebecca Kesselring
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 3.  Molecular Mechanisms of Tumor Immunomodulation in the Microenvironment of Colorectal Cancer.

Authors:  Dorothea Plundrich; Sophia Chikhladze; Stefan Fichtner-Feigl; Reinhild Feuerstein; Priscilla S Briquez
Journal:  Int J Mol Sci       Date:  2022-03-03       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.